If you have been reading about lyophilisation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-06. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical verification typically combines reversed-phase high-performance liquid chromatography with ultraviolet-visible detection. The copper complex absorbs visible light near 600–630 nm, giving a characteristic blue signal. Mass spectrometry confirms molecular mass and can detect free peptide or mismatched copper stoichiometry. Copper content is often measured independently by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. Purity, counterion identity, and residual solvents are additional quality-control parameters that methods may address.
Solid GHK-Cu is generally stored as a dry powder under frozen conditions to limit degradation. The peptide bond can hydrolyze, and the copper center can be displaced by strong chelators such as EDTA. Aqueous solutions are less stable than the solid and may lose color or form precipitates over time. Temperature, pH, and oxygen exposure are the main variables that affect shelf life. Neutral to slightly acidic conditions tend to preserve the complex better than strongly alkaline media.
Stability depends on temperature, light exposure, moisture, and the presence of oxidizing or reducing agents. Solid material held dry and protected from light is generally more stable than aqueous solutions, which can undergo gradual degradation. Recommended storage in much of the literature is a freezer at around minus twenty degrees Celsius for long-term retention, with working aliquots kept cold and shielded from light. Repeated freeze-thaw cycles and alkaline pH are commonly noted as factors that accelerate loss of the intact complex, though exact degradation rates vary.
Analytical confirmation usually combines a separation method with a copper-specific measurement. Liquid chromatography or mass spectrometry establishes peptide identity and purity, while an elemental measurement quantifies the metal content. A frequent misconception is that any blue solution contains an intact copper peptide complex; color alone does not confirm structure, because free copper salts and degraded mixtures can also appear colored. Literature on efficacy is mixed, with in vitro findings often more dramatic than human evidence, and reviews note small sample sizes and short follow-up. Open questions include optimal concentration, skin penetration, and long-term effects.
| Property | Value | Notes |
|---|---|---|
| Physical state | Blue-violet solid | Typically supplied as lyophilized powder |
| Storage temperature | −20 °C or below | Desiccated, protected from light |
| Working stability | Hours to days at 2–8 °C | Depends on concentration and buffer |
| Identity test | RP-HPLC with UV-Vis | Visible absorbance near 600–630 nm |
| Copper assay | ICP-MS or AAS | Metal content confirms stoichiometry |
Analytical verification commonly relies on high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Spectroscopic methods such as UV-visible absorption and electron paramagnetic resonance can probe the metal centre itself, since the d9 configuration of copper(II) produces characteristic signals. Elemental analysis or plasma-based techniques quantify copper content. Because each method reports a different aspect of the same sample, purity figures are most meaningful when the technique and its detection wavelength are stated alongside the value.
Stability of the complex in solution depends on pH, temperature, and the presence of competing ligands. It is generally described as more resistant to breakdown than the metal-free chain, since coordination reduces susceptibility to enzymatic attack. Oxidation and hydrolysis can nevertheless proceed over time in aqueous media. Storage guidance in laboratory settings commonly involves refrigeration, protection from light, and avoidance of strongly alkaline conditions. Published data on long-term behaviour vary considerably and depend on the specific matrix.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
Several names circulate for the same material, which complicates literature searches. Cosmetic ingredient lists often use copper tripeptide-1, while older biochemistry papers use glycyl-L-histidyl-lysine or its abbreviation GHK. The copper complex is sometimes written as GHK-Cu(II) to make the oxidation state explicit. Terminology is not fully standardized, so matching a compound across sources requires attention to the exact sequence, the counterion, and the stated copper content. Reviews that compare studies must account for these naming differences before drawing conclusions.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
The peptide sequence places a histidine in the middle, and this residue dominates metal binding. Copper(II) coordinates through the imidazole nitrogen of histidine and the terminal amino group, forming a stable chelate ring system. Loss of the copper ion leaves the free tripeptide, which has different solubility and reactivity. This structural detail matters because assays that measure only the peptide backbone can miss whether copper is still bound to it.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
Mechanistic accounts focus on how the complex delivers copper and how the released peptide interacts with the extracellular matrix. Copper is an essential cofactor for lysyl oxidase and other enzymes involved in collagen and elastin cross-linking, and GHK is one of several peptides able to carry the metal. Reported effects include altered gene expression in fibroblasts and changes in matrix metalloproteinase activity, although many of these findings come from cell culture rather than whole organisms. The relative contribution of the peptide backbone, the copper ion, and downstream copper metabolism is not fully resolved.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
Prior to this, babies born in different states had received different levels of screening. On April 24, 2008, President George W. Bush signed into law the Newborn Screening Saves Lives Act of 2007. This act was enacted to increase awareness among parents, health professionals, and the public on testing newborns to identify certain disorders. It also sought to improve, expand, and enhance current newborn screening programs at the state level.
characterizes the potential for initial spread of an infectious person in a naive population, assuming the change in the susceptible population is negligible during the initial spread. A linear system of ODEs can always be described by a matrix. So, the next step is to construct a linear positive operator that provides the next generation of infected people when applied to the present generation. Note that this operator (matrix) is responsible for the number of infected people, not all the compartments. Iteration of this operator describes the initial progression of infection within the heterogeneous population. So comparing the spectral radius of this operator to unity determines whether the generations of infected people grow or not.
Bakker sold colloidal silver supplements that he advertised as a panacea. In March 2020, the office of the Attorney General of New York ordered Bakker to cease making false medicinal claims about his supplements' alleged ability to cure the 2019–2020 strains of coronavirus, and the Federal Trade Commission and the Food and Drug Administration also sent a warning letter to Bakker about his claims regarding the supplements and coronavirus. Missouri attorney general Eric Schmitt and Arkansas attorney general Leslie Rutledge filed lawsuits against Bakker for allegedly pushing the supplements as a treatment for the virus. In the State lawsuit against him, Bakker is represented by former Missouri governor Jay Nixon, who has argued for the suit to be dismissed. Nixon says that the allegations made in the lawsuit are false, stating: "Bakker is being unfairly targeted by those who want to crush his ministry and force his Christian television program off the air." In April 2020, prohibited from receiving credit card transactions, Bakker disclosed to his viewers that his ministry was on the brink of filing for bankruptcy and urgently petitioned them for donations. The following month, GEB America and World Harvest Television dropped Bakker's program from their networks after DirecTV owner AT&T asked channels to reconsider airing the show. AT&T made the request of its channels in response to a deplatforming campaign from the liberal Christian group Faithful America. On May 8, 2020, Lori Bakker announced that Jim Bakker had suffered a stroke that his son Jay described as "minor".
After the Second World War, the United States and the Soviet Union were doomed to be antagonists. ... There probably was never any real possibility that the post-1945 relationship could be anything but hostility verging on conflict. ... Traditions, belief systems, propinquity, and convenience ... all combined to stimulate antagonism, and almost no factor operated in either country to hold it back. From that view of "post-revisionism" emerged a line of inquiry that examines how Cold War actors perceived various events and the degree of misperception involved in the failure of the two sides to reach common understandings of their wartime alliance and their disputes. After the opening of the Soviet archives, John Lewis Gaddis began to argue that the Soviets should be held more accountable for conflict. According to Gaddis, Stalin was in a much better position to compromise than his Western counterparts, given his much broader power within his own regime than Truman, who was often undermined by vociferous political opposition at home. Asking if it would have been possible to predict that the wartime alliance would fall apart within a matter of months, leaving in its place nearly a half century of cold war, Gaddis wrote in his 1997 book We Now Know: Rethinking Cold War History the following:
Sources: en.wikipedia.org
David L. Eaton (born August 15, 1952) is an American toxicologist and professor Emeritus at the University of Washington (UW). His work focuses on risk assessment, gene-environment interactions, environmental carcinogenesis, and xenobiotic biotransformation. Over his career, Eaton has chaired committees for the National Academies of Sciences, Engineering, and Medicine (NASEM), held academic administration positions at the University of Washington, and presided over the Society of Toxicology (SOT).
In May 1878 Eddy brought a case against Daniel Spofford, in Salem, Massachusetts, for practicing mesmerism. It came to be known as the second Salem witchcraft trial. The case was filed in the name of one of Spofford's patients, Lucretia Brown, who said that he had bewitched her, though Eddy appeared in court on Brown's behalf. In preparation for the hearing, Eddy organized a 24-hour watch at 8 Broad Street, during which she asked 12 students to think about Spofford for two hours each and block malicious mesmerism from him. She arrived at the court with 20 supporters, including Amos Bronson Alcott (a "cloud of witnesses," according to the Boston Globe), but Judge Horace Gray dismissed the case. The attempt to have Spofford tried was not the end of the dispute. In October 1878 Eddy's husband and another student, Edward Arens, were charged with conspiring to murder Spofford. A barman said they had offered him $500 to do it; after a complex series of claims and counter-claims, the charges were dropped when a witness retracted his statement. Eddy attributed the allegation to a plot by former students to undermine sales of the second edition of Science and Health, just published. Her lawyer had to apply for an attachment order against her house to collect his fee.
===== Waldez Góes ===== At the beginning of January, the NGO Transparency International issued a statement criticizing the choice of Waldez Goés, former Governor of Amapá and affiliated with the PDT, as Ministry of National Integration, due to his previous prison sentence for misappropiation of public resources. On its official Twitter profile, the institution published:This week, a man sentenced to prison for embezzlement of public resources was sworn in as Minister of National Integration. He entered through the Centrão quota, which can undermine any government, on the right or on the left. In 2019, Waldez Goés was sentenced by the STJ (Supreme Court of Justice) to 6 years in prison for embezzlement. His defence filed an appeal, which is pending at the STF (Supreme Federal Court) following a request from Minister Alexandre de Moraes. Still, despite the seriousness of the case, he was sworn in as Minister of the Lula Government. According to several sources, Waldez was presented and nominated by Davi Alcolumbre (União Brasil), senator for Amapá and former President of the Senate from 2019 to 2021. Two days before leaving the Government of Amapá, Waldez announced work to pave a highway that connects the state capital, Macapá, to the south of the state.
=== Pharmacokinetics === Hydroxylated metabolites can be detected in urine for up to 10 days after consumption. Mesocarb had erroneously been referred to as a prodrug of amphetamine. However, this was based on older literature that relied on gas chromatography as an analytical method. Subsequently, with the advent of mass spectroscopy, it has been shown that presence of amphetamine in prior studies was an artifact of the gas chromatography method. More recent studies using mass spectroscopy show that negligible levels of amphetamine are released from mesocarb metabolism.
The half-life of uranium-236 is too short for it to be primordial, though it has been identified as an extinct progenitor of its alpha decay daughter, thorium-232. Uranium-236 occurs in spent nuclear fuel when neutron capture on 235U does not induce fission, or as a decay product of plutonium-240. Uranium-236 is not fertile, as three more neutron captures are required to produce fissile 239Pu, and is not itself fissile; as such, it is considered long-lived radioactive waste. Uranium-234 is a member of the uranium series and occurs in equilibrium with its progenitor, 238U; it undergoes alpha decay with a half-life of 245,500 years and decays to lead-206 through a series of relatively short-lived isotopes. Uranium-233 undergoes alpha decay with a half-life of 160,000 years and, like 235U, is fissile. It can be bred from thorium-232 via neutron bombardment, usually in a nuclear reactor; this process is known as the thorium fuel cycle. Owing to the fissility of 233U and the greater natural abundance of thorium (three times that of uranium), 233U has been investigated for use as nuclear fuel as a possible alternative to 235U and 239Pu, though is not in widespread use as of 2022. The decay chain of uranium-233 forms part of the neptunium series and ends at nearly-stable bismuth-209 (half-life 2.01×1019 years) and stable thallium-205. Uranium-232 is an alpha emitter with a half-life of 68.9 years. This isotope is produced as a byproduct in production of 233U and is considered a nuisance, as it is not fissile and decays through short-lived alpha and gamma emitters such as 208Tl.
Sources: en.wikipedia.org
Dry powder is typically stored frozen at −20 °C or lower, protected from moisture and light. Short-term working amounts may be kept refrigerated. Avoiding repeated temperature changes helps preserve the material.
Reversed-phase HPLC with UV-visible detection is common because the copper complex absorbs visible light. Mass spectrometry provides molecular mass confirmation. Copper-specific methods such as ICP-MS quantify the metal content.
The blue color comes from copper-ligand interactions. Displacement of copper by chelators or changes in pH can shift or diminish the color. Such changes often indicate that the complex has been altered.
Freezer temperatures are common for long-term retention. Light and moisture exposure should be limited. Working portions are best kept cold and used without repeated freeze-thaw cycles.